These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Advances in cell-type specific delivery of RNAi-based therapeutics. Dykxhoorn DM IDrugs; 2010 May; 13(5):325-31. PubMed ID: 20432190 [TBL] [Abstract][Full Text] [Related]
10. The silent treatment: siRNAs as small molecule drugs. Dykxhoorn DM; Palliser D; Lieberman J Gene Ther; 2006 Mar; 13(6):541-52. PubMed ID: 16397510 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of RNA interference for neurological disorders. Sah DW Life Sci; 2006 Oct; 79(19):1773-80. PubMed ID: 16815477 [TBL] [Abstract][Full Text] [Related]
12. Nonviral in vivo delivery of therapeutic small interfering RNAs. Aigner A Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447 [TBL] [Abstract][Full Text] [Related]
13. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery. Singh SK; Hajeri PB Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous short-interfering RNA therapy. Geusens B; Sanders N; Prow T; Van Gele M; Lambert J Expert Opin Drug Deliv; 2009 Dec; 6(12):1333-49. PubMed ID: 19941411 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in therapy for glioblastoma. Clarke J; Butowski N; Chang S Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224 [TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274 [TBL] [Abstract][Full Text] [Related]
17. Modulation of gene expression by siRNA in hematopoietic cells. Scherr M; Eder M Curr Opin Drug Discov Devel; 2005 Mar; 8(2):262-9. PubMed ID: 15782549 [TBL] [Abstract][Full Text] [Related]
18. Prospects of RNA interference therapy for cancer. Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059 [TBL] [Abstract][Full Text] [Related]
19. Using RNAi in the clinic. Dev KK IDrugs; 2006 Apr; 9(4):279-82. PubMed ID: 16596482 [TBL] [Abstract][Full Text] [Related]
20. RNAi: a novel antisense technology and its therapeutic potential. Dallas A; Vlassov AV Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]